Transcatheter aortic valve implantation is an increasingly viable treatment for patients with severe symptomatic aortic stenosis who are not candidates for conventional surgery, despite ongoing concerns regarding specific complications.
Answers are grounded in this paper and cite their sources.
May support TAVI consideration in inoperable severe AS; leaves open durability and complication management for prospective study.
Transcatheter aortic valve implantation was developed to offer a therapeutic solution to patients with severe symptomatic aortic stenosis who are not candidates for conventional aortic valve replacement. The improvement in transcatheter aortic valve implantation outcomes is still of concern in the areas of stroke, vascular injury, heart block, paravalvular regurgitation and valve durability. Concomitantly, the progress, both technical and in terms of material advances of transcatheter valve systems, as well as in patient selection, renders transcatheter aortic valve implantation an increasingly viable treatment for more and more patients with structural heart disease.
No takes yet. Share an insight, caveat, or question.
Oliemy et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: